• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

空腹状态下、与食物同服时以及与抗酸剂同服时异烟肼的药代动力学。

Pharmacokinetics of isoniazid under fasting conditions, with food, and with antacids.

作者信息

Peloquin C A, Namdar R, Dodge A A, Nix D E

机构信息

Department of Medicine, National Jewish Medical and Research Center, Denver, Colorado 80206, USA.

出版信息

Int J Tuberc Lung Dis. 1999 Aug;3(8):703-10.

PMID:10460103
Abstract

STUDY OBJECTIVES

To determine the intra- and intersubject variability in and the effects of food or antacids on the pharmacokinetics of isoniazid (INH).

DESIGN

Randomized, four-period cross-over Phase I study in 14 healthy male and female volunteers. Subjects ingested single doses of INH 300 mg under fasting conditions twice, with a high-fat meal, and with aluminum-magnesium antacid. They also received standard doses of rifampin, pyrazinamide, and ethambutol.

RESULTS

Serum was collected for 48 hours, and assayed by high performance liquid chromatography (HPLC). Data were analyzed using noncompartmental methods and a compartmental analysis using nonparametric expectation maximization. Both fasting conditions produced similar results: a mean INH Cmax of 5.53 +/- 2.92 microg/ml, Tmax of 1.02 +/- 1.10 hours, and AUC0-infinity of 20.16 +/- 12.45 microg x hr/ml. These findings are similar to those reported previously. Antacids did not alter these parameters significantly (Cmax of 5.62 +/- 2.53 microg/ml, Tmax of 0.71 +/- 0.56 hours, and AUC0-infinity of 20.27 +/- 11.39 microg x hr/ml). In contrast, the high-fat meal recommended by the Food and Drug Administration reduced INH Cmax by 51% (2.73 +/- 1.70 microg/ml), nearly doubled Tmax (1.93 +/- 1.61 hours), and reduced AUC0-infinity by 12% (17.72 +/- 10.32 microg x hr/ml).

CONCLUSIONS

These changes in Cmax, Tmax, and AUC0-infinity can be avoided by giving INH on an empty stomach whenever possible.

摘要

研究目的

确定异烟肼(INH)药代动力学的受试者内和受试者间变异性以及食物或抗酸剂对其的影响。

设计

对14名健康男性和女性志愿者进行的随机、四周期交叉I期研究。受试者在禁食条件下两次服用300毫克单剂量INH,一次与高脂餐同服,一次与铝镁抗酸剂同服。他们还接受了标准剂量的利福平、吡嗪酰胺和乙胺丁醇。

结果

采集血清48小时,并通过高效液相色谱法(HPLC)进行检测。数据采用非房室方法和使用非参数期望最大化的房室分析进行分析。两种禁食条件产生了相似的结果:INH的平均Cmax为5.53±2.92微克/毫升,Tmax为1.02±1.10小时,AUC0至无穷大为20.16±12.45微克·小时/毫升。这些发现与先前报道的相似。抗酸剂未显著改变这些参数(Cmax为5.62±2.53微克/毫升,Tmax为0.71±0.56小时,AUC0至无穷大为20.27±11.39微克·小时/毫升))。相比之下,美国食品药品监督管理局推荐的高脂餐使INH的Cmax降低了51%(2.73±1.70微克/毫升),Tmax几乎翻倍(1.93±1.61小时),AUC0至无穷大降低了12%(17.72±10.32微克·小时/毫升)。

结论

只要有可能,空腹服用INH可避免Cmax, Tmax和AUC0至无穷大的这些变化。

相似文献

1
Pharmacokinetics of isoniazid under fasting conditions, with food, and with antacids.空腹状态下、与食物同服时以及与抗酸剂同服时异烟肼的药代动力学。
Int J Tuberc Lung Dis. 1999 Aug;3(8):703-10.
2
Pharmacokinetics of pyrazinamide under fasting conditions, with food, and with antacids.空腹状态下、与食物同服以及与抗酸剂同服时吡嗪酰胺的药代动力学。
Pharmacotherapy. 1998 Nov-Dec;18(6):1205-11.
3
Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids.利福平在空腹条件下、与食物同服以及与抗酸剂同服时的药代动力学。
Chest. 1999 Jan;115(1):12-8. doi: 10.1378/chest.115.1.12.
4
Pharmacokinetics of ethambutol under fasting conditions, with food, and with antacids.空腹状态下、与食物同服以及与抗酸剂同服时乙胺丁醇的药代动力学。
Antimicrob Agents Chemother. 1999 Mar;43(3):568-72. doi: 10.1128/AAC.43.3.568.
5
Comparative bioequivalence study of rifampicin and isoniazid combinations in healthy volunteers.健康志愿者中利福平与异烟肼组合的比较生物等效性研究。
Int J Tuberc Lung Dis. 1999 Jul;3(7):627-31.
6
Pharmacokinetics and relative bioavailability of clofazimine in relation to food, orange juice and antacid.
Tuberculosis (Edinb). 2004;84(6):365-73. doi: 10.1016/j.tube.2004.04.001.
7
A study on the pharmacokinetics of chlorzoxazone in healthy Thai volunteers.氯唑沙宗在泰国健康志愿者体内的药代动力学研究。
J Med Assoc Thai. 2007 Jan;90(1):160-6.
8
Reduced oral itraconazole bioavailability by antacid suspension.抗酸剂混悬液降低口服伊曲康唑的生物利用度。
J Clin Pharm Ther. 2005 Jun;30(3):201-6. doi: 10.1111/j.1365-2710.2005.00632.x.
9
Effect of food on the pharmacokinetics of rifalazil, a novel antibacterial, in healthy male volunteers.食物对新型抗菌药物利福拉齐在健康男性志愿者体内药代动力学的影响。
J Clin Pharmacol. 2007 Jul;47(7):841-9. doi: 10.1177/0091270007300745. Epub 2007 Apr 26.
10
Pharmacokinetics of ethionamide administered under fasting conditions or with orange juice, food, or antacids.空腹条件下或与橙汁、食物或抗酸剂一起服用时乙硫异烟胺的药代动力学。
Antimicrob Agents Chemother. 2001 Mar;45(3):810-4. doi: 10.1128/AAC.45.3.810-814.2001.

引用本文的文献

1
The Development of an Age-Appropriate Fixed Dose Combination for Tuberculosis Using Physiologically-Based Pharmacokinetic Modeling (PBBM) and Risk Assessment.使用基于生理学的药代动力学模型(PBBM)和风险评估开发适合年龄的结核病固定剂量复方制剂。
Pharmaceutics. 2024 Dec 12;16(12):1587. doi: 10.3390/pharmaceutics16121587.
2
Effect of Food Composition on the PK of Isoniazid Quantitatively Explained Using Physiologically Based Biopharmaceutics Modeling.基于生理的药代动力学模型定量解释食物成分对异烟肼药代动力学的影响。
AAPS J. 2024 Apr 24;26(3):54. doi: 10.1208/s12248-024-00923-9.
3
Isoniazid urine spectrophotometry for prediction of serum pharmacokinetics in adults with TB.
异烟肼尿液分光光度法预测成人结核病患者的血清药代动力学
IJTLD Open. 2024 Feb;1(2):90-95. doi: 10.5588/ijtldopen.23.0361.
4
Adequacy of the 10 mg/kg Daily Dose of Antituberculosis Drug Isoniazid in Infants under 6 Months of Age.6个月以下婴儿每日10mg/kg抗结核药物异烟肼剂量的充足性
Antibiotics (Basel). 2023 Jan 30;12(2):272. doi: 10.3390/antibiotics12020272.
5
Food effect risk assessment in preformulation stage using material sparing μFLUX methodology.在制剂前阶段使用材料节约型μFLUX方法进行食物效应风险评估。
ADMET DMPK. 2022 Oct 7;10(4):299-314. doi: 10.5599/admet.1476. eCollection 2022.
6
Therapeutic Drug Monitoring in Non-Tuberculosis Mycobacteria Infections.非结核分枝杆菌感染的治疗药物监测。
Clin Pharmacokinet. 2021 Jun;60(6):711-725. doi: 10.1007/s40262-021-01000-6. Epub 2021 Mar 10.
7
Population Pharmacokinetics and Bayesian Dose Adjustment to Advance TDM of Anti-TB Drugs.群体药代动力学与贝叶斯剂量调整推进抗结核药物治疗药物监测。
Clin Pharmacokinet. 2021 Jun;60(6):685-710. doi: 10.1007/s40262-021-00997-0. Epub 2021 Mar 6.
8
Induction of protective autophagy against apoptosis in HepG2 cells by isoniazid independent of the p38 signaling pathway.异烟肼通过独立于p38信号通路诱导HepG2细胞产生抗凋亡的保护性自噬。
Toxicol Res (Camb). 2016 Apr 4;5(3):963-972. doi: 10.1039/c5tx00470e. eCollection 2016 May 1.
9
Is IQG-607 a Potential Metallodrug or Metallopro-Drug With a Defined Molecular Target in ?IQG-607是否是一种具有明确分子靶点的潜在金属药物或前体金属药物?
Front Microbiol. 2018 May 1;9:880. doi: 10.3389/fmicb.2018.00880. eCollection 2018.
10
Isoniazid resistance levels of Mycobacterium tuberculosis can largely be predicted by high-confidence resistance-conferring mutations.结核分枝杆菌的异烟肼耐药水平很大程度上可以通过高可信度耐药相关突变来预测。
Sci Rep. 2018 Feb 19;8(1):3246. doi: 10.1038/s41598-018-21378-x.